Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 03, 2008. The report serves as a notification of a change in major shareholding interests rather than a financial performance report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding shareholder ownership and does not contain financial statements.
Material Changes
The material change reported is a notification from Legal & General Group plc regarding its interest in GlaxoSmithKline plc Ordinary shares. On September 01, 2008, Legal & General Group plc and its subsidiaries notified the issuer of their voting rights position.
- Shareholder: Legal & General Group plc (including Legal & General Investment Management Limited and Legal & General Assurance (Pensions Management) Limited).
- Transaction Date: September 01, 2008.
- Notification Date: September 03, 2008.
- Threshold Status: The total voting rights held remain below the 5% threshold.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a compliance notification under DTR 5.8.12 regarding the breakdown of voting rights.
Investor Verification Points
- Verify the total voting rights figure of 5,237,361,030 used as the basis for the percentage calculation.
- Confirm the specific breakdown of direct and indirect holdings within the Legal & General Group structure (e.g., LGAS, LGPL, PMC).
- Note that the reported holdings (approx. 261.9 million shares) represent less than 5% of total voting rights.